Back to search

Netherlands· NL-add031bf4d0d

SonoVue, 8 microliter/ml, poeder en solvens voor suspensie voor injectie

A schwefelhexafluorid, phospholipid-mikrosphären product containing zwavelhexafluoride, registered in Netherlands by Bracco International B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC V08DA05

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedSonoVue, 8 microliter/ml, poeder en s…ATCV08DA05REGISTER NO.NL-add031bf4d0dPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Schwefelhexafluorid, phospholipid-mikrosphären is registered in 11 of 19 countries.

Countries holding a registration under ATC V08DA05 (schwefelhexafluorid, phospholipid-mikrosphären), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose

Schwefelhexafluorid, phospholipid-mikrosphären · ATC V08DA05

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ZWAVELHEXAFLUORIDE
Manufacturer
Bracco International B.V.
Country
Netherlands (NL)
ATC code
V08DA05
ATC class
Schwefelhexafluorid, Phospholipid-Mikrosphären
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/01/177

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d9042aa6-9e9d-4256-9a65-63e0c093faba
GET /v1/drugs/d9042aa6-9e9d-4256-9a65-63e0c093faba?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder en oplosmiddel voor suspensie voor injectie",
  "route": "Intraveneus gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/sonovue-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Sulfur hexafluoride, phospholipid microspheres",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp71355",
  "excipients": [
    "DIPALMITOYLPHOSPHATIDYLGLYCEROLNATRIUM",
    "DISTEAROYLFOSFATIDYLCHOLINE, DL-",
    "MACROGOL 4000",
    "NATRIUMCHLORIDE",
    "PALMITINEZUUR",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "ZWAVELHEXAFLUORIDE"
  ],
  "leaflet_url": null,
  "authorised_at": "2001/05/16",
  "procedure_number": "EMEA/H/C/000303",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/01/177",
  "additional_monitoring": "N"
}

See everything about schwefelhexafluorid, phospholipid-mikrosphären.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.